02/14/2025 7:03 PM | Redmile Group, LLC (Filed by) Silence Therapeutics plc (Subject) Silence Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/11/2025 5:41 PM | Lombard Odier Asset Management Corp (0001491719) (Filed by) Silence Therapeutics plc (Subject) Silence Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/02/2025 3:32 PM | HELLUMS RHONDA LYNETTE (Reporting) Silence Therapeutics plc (Issuer) Silence Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2025 3:34 PM | Davidson Michael H. (Reporting) Silence Therapeutics plc (Issuer) Silence Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2025 3:36 PM | Ede-Golightly James (Reporting) Silence Therapeutics plc (Issuer) Silence Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2025 3:38 PM | Ross Iain (Reporting) Silence Therapeutics plc (Issuer) Silence Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2025 3:39 PM | Silence Therapeutics plc (Issuer) Silence Therapeutics (Issuer) TOOMAN CRAIG A (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2025 3:43 PM | Griffiths Richard Ian (Reporting) Silence Therapeutics plc (Issuer) Silence Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/02/2025 7:00 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2024 4:32 PM | Griffiths Richard Ian (Filed by) Silence Therapeutics plc (Subject) Silence Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/09/2024 7:12 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for SLN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
11/18/2024 3:54 PM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024 8:44 AM | Deep Track Capital, LP (Filed by) Silence Therapeutics plc (Subject) Silence Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 8:24 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024 4:20 PM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form F-3ASR | |
08/15/2024 8:05 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024 5:51 PM | Invus Global Management, LLC (Filed by) Silence Therapeutics plc (Subject) Silence Therapeutics (Subject)
| Form SC 13G/A | |
06/27/2024 6:40 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024 7:38 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 7:41 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024 1:21 PM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 11:15 PM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form EFFECT | |
05/08/2024 4:14 PM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form DEL AM | |
05/01/2024 3:37 PM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 7:36 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 6:00 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024 7:52 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/13/2024 6:10 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/23/2024 7:12 AM | Silence Therapeutics plc (Filer) Silence Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |